Physician profile
Andrew William Brown
NPI 1336201375
$5,933.31
in general payments reported to CMS, 2019-2025
26 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,975 · 2020: $790 · 2021: $1,378 · 2022: $393 · 2023: $26.84 · 2024: $50.46 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $2,343.67 | 2019-2020 | |
| Conformis, INC. | $1,985.35 | 2019-2022 | |
| Medacta USA, INC. | $181.95 | 2021-2023 | Moto Uni |
| Pacira Therapeutics, INC. | $157.64 | 2019-2021 | |
| Curonix LLC | $157.22 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Microport Orthopedics INC | $157.15 | 2019 | |
| Heraeus Medical, LLC. | $138.64 | 2022 | |
| Saluda Medical Americas, INC. | $126.91 | 2025 | Evoke |
| Impactortho, INC. | $117.21 | 2021 | |
| Ermi LLC | $115.25 | 2019 | |
| Depuy Synthes Sales INC. | $54.94 | 2019-2025 | |
| Embody, INC. | $52.50 | 2021 | |
| Dynasplint Systems INC. | $45.85 | 2021 | |
| Horizon Therapeutics Plc | $36.28 | 2019 | |
| Baxter Healthcare | $35.93 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $34.11 | 2024 | Iconix, Inspace |
| Bioventus LLC | $29.81 | 2019 | |
| Zimmer Biomet Holdings, INC. | $28.83 | 2019-2024 | Ventix, Tapestry |
| Ferring Pharmaceuticals INC. | $25.82 | 2021 | |
| Smith+Nephew, INC. | $19.08 | 2020 | |
| Eyevance Pharmaceuticals LLC | $17.64 | 2019 | |
| Zyla Life Sciences, INC. | $16.52 | 2019 | |
| Medtronic, INC. | $15.26 | 2022 | |
| Axogen | $14.40 | 2019 | |
| Vericel Corporation | $12.92 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.